Inmunoglobulinas intravenosas
Intravenous immunoglobulins
I. Mangues
Leído
8050
Vecesse ha leído el artículo
1207
Total PDF
6843
Total HTML
Información del artículo
ISSN: 11306343Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2099 8 | 245 | 0 | 245 |
| 2025 6 | 22 | 11 | 33 |
| 2025 5 | 69 | 27 | 96 |
| 2025 4 | 60 | 16 | 76 |
| 2025 3 | 75 | 24 | 99 |
| 2025 2 | 62 | 31 | 93 |
| 2025 1 | 67 | 36 | 103 |
| 2024 12 | 53 | 19 | 72 |
| 2024 11 | 56 | 28 | 84 |
| 2024 10 | 71 | 26 | 97 |
| 2024 9 | 63 | 12 | 75 |
| 2024 8 | 60 | 25 | 85 |
| 2024 7 | 44 | 23 | 67 |
| 2024 6 | 42 | 19 | 61 |
| 2024 5 | 71 | 24 | 95 |
| 2024 4 | 66 | 17 | 83 |
| 2024 3 | 69 | 13 | 82 |
| 2024 2 | 67 | 23 | 90 |
| 2024 1 | 53 | 20 | 73 |
| 2023 12 | 48 | 13 | 61 |
| 2023 11 | 67 | 29 | 96 |
| 2023 10 | 53 | 7 | 60 |
| 2023 9 | 80 | 25 | 105 |
| 2023 8 | 34 | 9 | 43 |
| 2023 7 | 44 | 7 | 51 |
| 2023 6 | 39 | 17 | 56 |
| 2023 5 | 54 | 20 | 74 |
| 2023 4 | 10 | 6 | 16 |
| 2023 3 | 38 | 17 | 55 |
| 2023 2 | 38 | 15 | 53 |
| 2022 1 | 37 | 3 | 40 |
| 2022 12 | 60 | 5 | 65 |
| 2022 11 | 51 | 8 | 59 |
| 2022 10 | 34 | 3 | 37 |
| 2022 9 | 62 | 19 | 81 |
| 2022 8 | 43 | 15 | 58 |
| 2022 7 | 30 | 7 | 37 |
| 2022 6 | 42 | 6 | 48 |
| 2022 5 | 74 | 15 | 89 |
| 2022 4 | 47 | 19 | 66 |
| 2022 3 | 59 | 15 | 74 |
| 2022 2 | 343 | 7 | 350 |
| 2021 1 | 62 | 12 | 74 |
| 2021 12 | 39 | 13 | 52 |
| 2021 11 | 63 | 8 | 71 |
| 2021 10 | 51 | 19 | 70 |
| 2021 9 | 46 | 22 | 68 |
| 2021 8 | 371 | 8 | 379 |
| 2021 7 | 59 | 20 | 79 |
| 2021 6 | 60 | 10 | 70 |
| 2021 5 | 51 | 8 | 59 |
| 2021 4 | 167 | 23 | 190 |
| 2021 3 | 72 | 8 | 80 |
| 2021 2 | 66 | 5 | 71 |
| 2020 1 | 74 | 10 | 84 |
| 2020 12 | 59 | 8 | 67 |
| 2020 11 | 54 | 5 | 59 |
| 2020 10 | 31 | 6 | 37 |
| 2020 9 | 28 | 7 | 35 |
| 2020 8 | 42 | 11 | 53 |
| 2020 7 | 26 | 9 | 35 |
| 2020 6 | 24 | 10 | 34 |
| 2020 5 | 52 | 14 | 66 |
| 2020 4 | 48 | 5 | 53 |
| 2020 3 | 55 | 5 | 60 |
| 2020 2 | 60 | 11 | 71 |
| 2020 1 | 47 | 4 | 51 |
| 2019 12 | 44 | 9 | 53 |
| 2019 11 | 28 | 1 | 29 |
| 2019 10 | 40 | 6 | 46 |
| 2019 9 | 57 | 2 | 59 |
| 2019 8 | 39 | 2 | 41 |
| 2019 7 | 60 | 9 | 69 |
| 2019 6 | 133 | 26 | 159 |
| 2019 5 | 246 | 9 | 255 |
| 2019 4 | 109 | 17 | 126 |
| 2019 3 | 61 | 9 | 70 |
| 2019 2 | 44 | 3 | 47 |
| 2019 1 | 33 | 4 | 37 |
| 2018 12 | 26 | 6 | 32 |
| 2018 11 | 43 | 3 | 46 |
| 2018 10 | 70 | 14 | 84 |
| 2018 9 | 26 | 8 | 34 |
| 2018 8 | 24 | 0 | 24 |
| 2018 7 | 14 | 0 | 14 |
| 2018 6 | 44 | 1 | 45 |
| 2018 5 | 35 | 1 | 36 |
| 2018 4 | 29 | 0 | 29 |
| 2018 3 | 23 | 0 | 23 |
| 2018 2 | 16 | 0 | 16 |
| 2018 1 | 12 | 0 | 12 |
| 2017 12 | 19 | 0 | 19 |
| 2017 11 | 20 | 1 | 21 |
| 2017 10 | 23 | 0 | 23 |
| 2017 9 | 21 | 1 | 22 |
| 2017 8 | 15 | 0 | 15 |
| 2017 7 | 14 | 0 | 14 |
| 2017 6 | 22 | 0 | 22 |
| 2017 5 | 19 | 1 | 20 |
| 2017 4 | 26 | 0 | 26 |
| 2017 3 | 30 | 1 | 31 |
| 2017 2 | 10 | 1 | 11 |
| 2016 1 | 12 | 1 | 13 |
| 2016 12 | 21 | 3 | 24 |
| 2016 11 | 27 | 1 | 28 |
| 2016 10 | 18 | 0 | 18 |
| 2016 9 | 23 | 1 | 24 |
| 2016 8 | 9 | 1 | 10 |
| 2016 7 | 12 | 4 | 16 |
| 2016 6 | 25 | 5 | 30 |
| 2016 5 | 32 | 3 | 35 |
| 2016 4 | 32 | 8 | 40 |
| 2016 3 | 30 | 2 | 32 |
| 2016 2 | 37 | 8 | 45 |
| 2015 1 | 28 | 10 | 38 |
| 2015 12 | 35 | 1 | 36 |
| 2015 11 | 23 | 3 | 26 |
| 2015 10 | 30 | 5 | 35 |
| 2015 9 | 26 | 3 | 29 |
| 2015 8 | 13 | 6 | 19 |
| 2015 7 | 19 | 1 | 20 |
| 2015 6 | 13 | 1 | 14 |
| 2015 5 | 17 | 3 | 20 |
| 2015 4 | 8 | 3 | 11 |
| 2015 3 | 15 | 2 | 17 |
| 2015 2 | 23 | 3 | 26 |
| 2015 1 | 18 | 3 | 21 |
| 2014 12 | 26 | 2 | 28 |
| 2014 11 | 20 | 6 | 26 |
| 2014 10 | 22 | 3 | 25 |
| 2014 9 | 16 | 2 | 18 |
| 2014 8 | 20 | 2 | 22 |
| 2014 7 | 37 | 3 | 40 |
| 2014 6 | 34 | 1 | 35 |
| 2014 5 | 23 | 2 | 25 |
| 2014 4 | 26 | 4 | 30 |
| 2014 3 | 26 | 3 | 29 |
| 2014 2 | 12 | 1 | 13 |
| 2014 1 | 18 | 3 | 21 |
| 2013 12 | 19 | 5 | 24 |
| 2013 11 | 23 | 1 | 24 |
| 2013 10 | 18 | 1 | 19 |
| 2013 9 | 14 | 0 | 14 |
| 2013 8 | 20 | 1 | 21 |
| 2013 7 | 20 | 0 | 20 |
Mostrar todo
